ALSA Research

New York, New York 10016

1 studies enrolling now · 1 studies all time

What they study most

HOMA-IR, Mobility Disability, Obesity & Overweight

Studies at this site

• Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss — Recruiting now